Abstract:Background In 2020, the current outbreak of Coronavirus Disease 2019(COVID-19) has constituted a global pandemic. But the question about the immune mechanism of patients with COVID-19 is unclear and cause particular concern to the world. Here, we launched a follow-up analysis of antibodies against SARS-CoV-2 of 192 COVID-19 patients, aiming to depict a kinetics profile of antibodies against SARS-CoV-2 and explore the related factors of antibodies expression against SARS-CoV-2 in COVID-19 patient. Methods A total of 192 COVID-19 patients enrolled in the designated hospital of Guangzhou, Guangzhou Eighth People’s Hospital, from January to February 2020 were selected as the study cohort. A cohort of 130 COVID-19 suspects who had been excluded from SARS-CoV-2 infected by negative RT-PCR result and 209 healthy people were enrolled in this study. Detection of IgM and IgG against SARS-CoV-2 were performed by Chemiluminescence immunoassay in different groups. Results It has been found that the seroconversion time of IgM against SARS-CoV-2 in most patients was 5-10 days after the symptoms onset, and then rose rapidly, reaching a peak around 2 to 3 weeks, and the median peak concentration was 2.705 AU / mL. The peak of IgM maintained within one week, and then enters the descending channel. IgG seroconverted later than or synchronously with IgM, reaching peaks around 3 to 4 weeks.The median peak concentration was 33.998AU / ml,which was higher than that of IgM. IgM titers begins to gradually decrease after reaching the peak in the 4th week, after the 8th week, a majority of IgM in patient’s serum started to turn negative. On the contrary, titers of IgG began to decline slightly after the fifth week, and more than 90% of results of patients were positive after 8 weeks. Additionally, the concentration of antibodies positively correlated with the severity of the disease and the duration of virus exist in host. Conclusion We depict a kinetics profile of antibodies against SARS-CoV-2 in COVID-19 patients and found out that the levels of antibodies were related to the disease severity, age, gender and virus clearance or continuous proliferation of COVID-19 patients. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement Guangzhou Science and Technology Program(No.202008010008),China ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: All patients in this study have signed the informed consent, and the experimental protocol was approved by the Ethics Committee of Guangzhou Eighth People's Hospital,China(No.20200547) . All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes The data that support the findings of this study are available from the corresponding author upon reasonable request.

[Primary Investigation on the Changing Mode of Plasma Specific IgG Antibody in SARS Patients and Their Physicians and Nurses].

Investigation on Serum Specific Anti-Sars Coronavirus IgM and IgG Antibodies in Physicians and Nurses Working in SARS Wards

Mass SARS-CoV-2 Molecular and Serological Screening of Medical Staff and Patients in Hangzhou, China: No Evidence of RNA Detection, Low Seroprevalence, and Limited Exposure Risk in the Hospital Setting.

Dynamic Changes in IgG and IgM Antibodies As Clinical Indicators During Recovery Stage in Patients with Severe Acute Respiratory Syndrome

Study on the Response of Specific Antibodies Against SARS-CoV in Patients Infected with SARS

The Follow-up Study on the Health Status of Convalescent Patients Recovered from SARS in Tianjin

[Prospective Clinical Study on Serum Immunity in IgG-antibodies Positive Patients Convalescent from Severe Acute Respiratory Syndrome].

[Covert infection of severe acute respiratory syndrome in health-care professionals and its relation to the workload and the type of work]

[A Follow Up Study of Total IgM, IgG, Nucleoprotein and Spike Protein Antibodies Against Severe Acute Respiratory Syndrome (SARS) Coronavirus in Patients with SARS].

Dynamic Changes of Viral Load and Antibodies Level in the Patients of Severe Acute Respiratory Syndrome

Evaluation of serum IgM and IgG antibodies in COVID‐19 patients by enzyme linked immunosorbent assay

Dynamic Characteristic Analysis of Antibodies in Patients with COVID-19: A 13-Month Study

Detection of Anti-Sars CoV IgG Antibody in Sera of Different Populations and Its Significance

Epidemiological, Clinical, Laboratorial and CT Imaging Features of Hospitalized Patients with Initially Negative Detection of SARS-CoV-2 in China

Serology of Severe Acute Respiratory Syndrome: Implications for Surveillance and Outcome

[Analysis of Medical Workers Suffered from SARS].

Investigating the Current Status of SARS-CoV-2 Antibodies in Hospital Staff

Surveillance of SARS-CoV-2 antibodies of patients in the local affected area during Wuhan lockdown

[The Clinical Characteristics and Outcome of 45 Early Stage Patients with SARS].

Antibody responses to SARS‐CoV‐2 in healthy individuals returning to Shenzhen

Study on the expression levels of antibodies against SARS CoV 2 at different period of disease and its related factors in 192 cases of COVID 19 patients